Ziopharm surges, extends recent gains

Shares of Ziopharm Oncology (ZIOP +9.9%) are trading sharply higher on the session.

Earlier, the company announced that it, along with Intrexon (XON +0.1%), will present at the International Conference on Molecular Targets and Cancer Therapeutics this month.

The poster presentations will highlight ZIOP's "monogenic system which enables the controlled delivery of therapeutic interleukin-12, in a brain tumor model," as well as other pipeline programs. (PR)

With today's gains, the shares are up ~52% since September 27, when the company presented at the Biotech Industry Conference in New York.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs